Synthesis of 2-Aminopyrimidine Derivatives and Their Evaluation as <i>β</i>-Glucuronidase Inhibitors: In Vitro and In Silico Studies
Sarosh Iqbal,
Nimra Naveed Shaikh,
Khalid Mohammed Khan,
Shumaila Kiran,
Sehrish Naz,
Zaheer Ul-Haq,
Shahnaz Perveen,
M. Iqbal Choudhary
Affiliations
Sarosh Iqbal
Department of Applied Chemistry, Government College University, Faisalabad 38000, Pakistan
Nimra Naveed Shaikh
H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
Khalid Mohammed Khan
H. E. J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
Shumaila Kiran
Department of Applied Chemistry, Government College University, Faisalabad 38000, Pakistan
Sehrish Naz
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
Zaheer Ul-Haq
Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan
Currently the discovery and development of potent β-glucuronidase inhibitors is an active area of research due to the observation that increased activity of this enzyme is associated with many pathological conditions, such as colon cancer, renal diseases, and infections of the urinary tract. In this study, twenty-seven 2-aminopyrimidine derivatives 1–27 were synthesized by fusion of 2-amino-4,6-dichloropyrimidine with a variety of amines in the presence of triethylamine without using any solvent and catalyst, in good to excellent yields. All synthesized compounds were characterized by EI-MS, HREI-MS and NMR spectroscopy. Compounds 1–27 were then evaluated for their β-glucuronidase inhibitory activity, and among them, compound 24 (IC50 = 2.8 ± 0.10 µM) showed an activity much superior to standard D-saccharic acid 1,4-lactone (IC50 = 45.75 ± 2.16 µM). To predict the binding mode of the substrate and β-glucuronidase, in silico study was performed. Conclusively, this study has identified a potent β-glucuronidase inhibitor that deserves to be further studied for the development of pharmaceutical products.